Assessing The Change In Weight Over A Time In Patients Treated With Doltegravir And Raltegravir (Integrase Inhibitors) In Japanese HIV Infected Patients
Latest Information Update: 27 Jan 2020
At a glance
- Drugs Dolutegravir (Primary) ; Raltegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions
Most Recent Events
- 27 Jan 2020 New trial record